BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2022 2:24:59 AM | Browse: 597 | Download: 1467
 |
Received |
|
2022-05-12 03:58 |
 |
Peer-Review Started |
|
2022-05-12 04:00 |
 |
First Decision by Editorial Office Director |
|
2022-06-16 02:54 |
 |
Return for Revision |
|
2022-06-16 02:54 |
 |
Revised |
|
2022-07-09 06:07 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-09-15 03:28 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-09-16 11:11 |
 |
Articles in Press |
|
2022-09-16 11:11 |
 |
Edit the Manuscript by Language Editor |
|
2022-09-07 12:57 |
 |
Typeset the Manuscript |
|
2022-09-22 00:38 |
 |
Publish the Manuscript Online |
|
2022-10-21 02:24 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yun Zheng, Chen-Yu Zhu, Jing Lin, Wang-Shan Chen, Yu-Jie Wang, Hong-Ye Fu and Qiong Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Qiong Zhao, PhD, Doctor, Doctor, Zhejiang University School of Medicine, Zhejiang University, No. 866 Yuhangtang Road, Xihu District, Hangzhou 310030, Zhejiang Province, China. jade1972@126.com |
| Key Words |
Programmed cell death protein 1; Immunotherapy; Hypophysitis; Lung cancer; Case reports |
| Core Tip |
Hypophysitis induced by programmed cell death 1 protein (PD-1) inhibitor treatment in non-small cell lung cancer (NSCLC) was rarely reported. In this study, we report three patients with NSCLC who developed hypophysitis induced by PD-1 immune checkpoint inhibitor treatment. Our study suggested that unexpected fatigue, appetite decreases, nausea, vomiting, hoarse voice, bucking, and difficulty breathing were largely correlated with immune-related hypophysitis. We also found that the clinical prognosis of patients with hypophysitis was related to the dose of steroid therapy. This work provided a reference for the diagnosis and timely treatment of hypophysitis in the clinic. |
| Publish Date |
2022-10-21 02:24 |
| Citation |
Zheng Y, Zhu CY, Lin J, Chen WS, Wang YJ, Fu HY, Zhao Q. Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports. World J Clin Cases 2022; 10(30): 11049-11058 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i30/11049.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i30.11049 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.